COMMUNIQUÉS West-GlobeNewswire

European CHMP Maintains Negative Opinion on Portola Pharmaceuticals’ Betrixaban Following Appeal

27/07/2018 - 14:24

SOUTH SAN FRANCISCO, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]

Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa.

27/07/2018 - 14:00

Results of Phase 1 Safety Study of SBP-101 for Pancreatic Ductal Adenocarcinoma PancreasFest is an International Conference of Physicians and Scientists Focused on Pancreatic Diseases MINNEAPOLIS, MN, July 27, 2018 ( [...]

Delcath Amends Phase 3 Ocular Melanoma Trial Protocol

27/07/2018 - 14:00

Revision to Nonrandomized (Single Arm) Study Reduces Trial Size Enrollment Requirement Enrollment Anticipated to be Completed by First Half 2019 NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: [...]

Tonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 HONOR Study of Tonmya® in Military-Related PTSD

27/07/2018 - 14:00

HONOR Study will Stop due to Inadequate Separation from Placebo at Week-12 Results at Week-4 Demonstrated Meaningful Clinical Improvement Company Plans to Meet with FDA to Discuss Next Steps for this Breakthrough [...]

Samumed Presents Positive Preclinical Data on SM07883 at 2018 Alzheimer’s Association International Conference® (AAIC®)

27/07/2018 - 14:00

Data supports SM07883 as a potential treatment for chronic tauopathies such as Alzheimer’s disease Company expects SM07883 to enter first-in-man studies in fall 2018 SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- Samumed [...]

eFFECTOR Initiates Dosing of eFT508 (tomivosertib) in a Phase 2 Add-on (CPI-A) Trial in Combination with Checkpoint Inhibitors to Treat Patients with Insufficient Response to Checkpoint Inhibitors Alone

27/07/2018 - 13:30

SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that it has dosed the first [...]

BeiGene Announces Proposed Hong Kong Initial Public Offering and Global Offering

27/07/2018 - 13:08

CAMBRIDGE, Mass. and BEIJING, China, July 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]

Resonant to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9th at 1:30 p.m. Pacific Daylight Time

27/07/2018 - 13:05

GOLETA, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, announced it will [...]

Auxly Announces Listing of Warrants

27/07/2018 - 13:00

VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (the " Company ") is pleased to announce that it has received the approval of the TSX Venture Exchange (" TSXV ") [...]

CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center

27/07/2018 - 10:24

Humanized Model Expansion Program begins with PD-1, CTLA-4, and CD137 Models SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing [...]

Status of Orphan designation of Apealea in the European Union

27/07/2018 - 08:50

Oasmia Pharmaceutical AB (NASDAQ: OASM) herewith announces that Apealea was designated as an orphan medicine by the European Commission in 2006 and alongside the procedure of the application for assessing a Market [...]

Chi-Med Reports 2018 Interim Results and Updates Shareholders on Key Clinical Programs

27/07/2018 - 08:00

LONDON, July 27, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM:HCM) (Nasdaq:HCM) today announces its unaudited financial results for the six months ended June 30, 2018 and updates [...]

DBV Technologies Reports June 30, 2018 Cash Position

27/07/2018 - 07:31

Montrouge, France, July 27, 2018 DBV Technologies Reports June 30, 2018 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and cash equivalents as of [...]

DBV Technologies publie sa position de trésorerie au 30 Juin 2018

27/07/2018 - 07:31

Montrouge, France, le 27 Juillet (7H30 CEST), 2018 DBV Technologies publie sa position de trésorerie au 30 Juin 2018 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]

Lefebvre family inspired by Terry Fox while walking across Canada for cancer research

27/07/2018 - 07:11

HALLVILLE, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- On May 1, Jimmy Lefebvre and his family left his parents’ home in Grande Prairie, Alberta to embark on a 5,700-kilometre walk across Canada in honour of his late [...]

Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million

27/07/2018 - 02:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced the pricing of its underwritten public offering of 18,181,818 ordinary shares at a [...]

Scythian Biosciences Announces Director Resignation

27/07/2018 - 00:52

TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) today announced [...]

Adherium Receives Additional U.S. FDA 510(k) Clearance, Setting in Motion a Full U.S. Consumer Launch of the Hailie™ Solution

27/07/2018 - 00:34

SAN MATEO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health platform that improves medication adherence, patient outcomes and engagement, today announced the U.S. Food and [...]

National Research Corporation to Broadcast its 2018 Second Quarter Conference Call Live on the Internet

26/07/2018 - 23:00

Lincoln, Nebraska, July 26, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 second quarter earnings conference call on [...]